PointofLaw.com

FORUM FEATURED DISCUSSIONS PoL COLUMNS LEGAL EXPERTS ARTICLES BOOKS PODCASTS LINKS MASTHEAD ADVANCED SEARCH

FORUM

« Around the web, February 19 | "Polluting Medical Judgment? False Assumptions in the Pursuit of False Claims Regarding Off-Label Prescribing" »

February 19, 2008


Anticonvulsants and suicidality, cont'd

Beck and Herrmann, blogging on the same New York Times story we did, raise a fascinating point about the possible tendency of drug trials to generate false positives as to a risk of suicidality. No matter what a drug's actual effects, they say, there may be reason to "expect more reports of suicidal behavior in the drug group than in the placebo group".

Posted by Walter Olson at 12:15 AM | TrackBack (0)



categories:
Products Liability









 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.